Proteolysis of SARS-associated coronavirus spike glycoprotein - PubMed (original) (raw)

Proteolysis of SARS-associated coronavirus spike glycoprotein

Graham Simmons et al. Adv Exp Med Biol. 2006.

No abstract available

PubMed Disclaimer

Similar articles

• SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry.
  Huang IC, Bosch BJ, Li W, Farzan M, Rottier PM, Choe H. Huang IC, et al. Adv Exp Med Biol. 2006;581:335-8. doi: 10.1007/978-0-387-33012-9_60. Adv Exp Med Biol. 2006. PMID: 17037556 Free PMC article. No abstract available.
• Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide.
  Bosch BJ, Bartelink W, Rottier PJ. Bosch BJ, et al. J Virol. 2008 Sep;82(17):8887-90. doi: 10.1128/JVI.00415-08. Epub 2008 Jun 18. J Virol. 2008. PMID: 18562523 Free PMC article.
• Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein.
  Fukushi S, Mizutani T, Saijo M, Matsuyama S, Taguchi F, Kurane I, Morikawa S. Fukushi S, et al. Adv Exp Med Biol. 2006;581:293-6. doi: 10.1007/978-0-387-33012-9_50. Adv Exp Med Biol. 2006. PMID: 17037546 Free PMC article. No abstract available.
• The SARS-CoV S glycoprotein.
  Xiao X, Dimitrov DS. Xiao X, et al. Cell Mol Life Sci. 2004 Oct;61(19-20):2428-30. doi: 10.1007/s00018-004-4257-y. Cell Mol Life Sci. 2004. PMID: 15526150 Free PMC article. Review.
• Insights from the association of SARS-CoV S-protein with its receptor, ACE2.
  Li W, Choe H, Farzan M. Li W, et al. Adv Exp Med Biol. 2006;581:209-18. doi: 10.1007/978-0-387-33012-9_36. Adv Exp Med Biol. 2006. PMID: 17037532 Free PMC article. Review. No abstract available.

Cited by

• The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors.
  Pišlar A, Mitrović A, Sabotič J, Pečar Fonović U, Perišić Nanut M, Jakoš T, Senjor E, Kos J. Pišlar A, et al. PLoS Pathog. 2020 Nov 2;16(11):e1009013. doi: 10.1371/journal.ppat.1009013. eCollection 2020 Nov. PLoS Pathog. 2020. PMID: 33137165 Free PMC article. Review.
• Increased LAMP1 Expression Enhances SARS-CoV-1 and SARS-CoV-2 Production in Vero-Derived Transgenic Cell Lines.
  Dolskiy AA, Grishchenko IV, Bodnev SA, Nazarenko AA, Smirnova AM, Matveeva AK, Bulychev LE, Ovchinnikova AS, Tregubchak TV, Zaykovskaya AV, Imatdinov IR, Pyankov OV, Gavrilova EV, Maksyutov RA, Yudkin DV. Dolskiy AA, et al. Mol Biol. 2022;56(3):463-468. doi: 10.1134/S0026893322030050. Epub 2022 Jun 3. Mol Biol. 2022. PMID: 35693978 Free PMC article.
• Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers.
  Costello DA, Millet JK, Hsia CY, Whittaker GR, Daniel S. Costello DA, et al. Biomaterials. 2013 Oct;34(32):7895-904. doi: 10.1016/j.biomaterials.2013.06.034. Epub 2013 Jul 22. Biomaterials. 2013. PMID: 23886734 Free PMC article.
• Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.
  Porotto M, Orefice G, Yokoyama CC, Mungall BA, Realubit R, Sganga ML, Aljofan M, Whitt M, Glickman F, Moscona A. Porotto M, et al. J Virol. 2009 May;83(10):5148-55. doi: 10.1128/JVI.00164-09. Epub 2009 Mar 4. J Virol. 2009. PMID: 19264786 Free PMC article.
• Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
  Belouzard S, Chu VC, Whittaker GR. Belouzard S, et al. Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6. doi: 10.1073/pnas.0809524106. Epub 2009 Mar 24. Proc Natl Acad Sci U S A. 2009. PMID: 19321428 Free PMC article.

References

1. 1. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. doi: 10.1038/nature02145. - DOI - PMC - PubMed
2. 1. Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ. pH-Dependent entry of SARS-CoV is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 2004;78:5642–5650. doi: 10.1128/JVI.78.11.5642-5650.2004. - DOI - PMC - PubMed
3. 1. Marzi A, Gramberg T, Simmons G, Moller P, Rennekamp A, Krumbiegel M, Geier M, Eisemann J, Turza N, Saunier B, Steinkasserer A, Becker S, Bates P, Hofmann H, Pohlmann S. DC-SIGN and DC-SIGNR interact with Marburg virus and the S protein of SARS-CoV. J. Virol. 2004;78:12090–12095. doi: 10.1128/JVI.78.21.12090-12095.2004. - DOI - PMC - PubMed
4. 1. Jeffers S, Tusell S, Gillim-Ross L, Hemmila E, Achenbach J, Babcock G, Thomas W, Jr., Thackray L, Young M, Mason R, Ambrosino D, Wentworth D, Demartini J, Holmes K. CD209L (L-SIGN) is a receptor for SARS-CoV. Proc. Natl. Acad. Sci. USA. 2004;101:15748–15753. doi: 10.1073/pnas.0403812101. - DOI - PMC - PubMed
5. 1. Gramberg T, Hofmann H, Moller P, Lalor PF, Marzi A, Geier M, Krumbiegel M, Winkler T, Kirchhoff F, Adams DH, Becker S, Munch J, Pohlmann S. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology. 2005;340:224–236. doi: 10.1016/j.virol.2005.06.026. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

• R01 AI43455/AI/NIAID NIH HHS/United States
• R21 AI058701/AI/NIAID NIH HHS/United States
• R21 AI059172/AI/NIAID NIH HHS/United States
• U54 AI057168/AI/NIAID NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Springer

• Miscellaneous

  • NCI CPTAC Assay Portal